ÂÜÀòÂÒÂ×

Nikola Trbovic is a seasoned professional in the biotechnology and investment sectors, currently serving as a Partner at SV Health Investors since January 2022. With extensive experience on various boards, Nikola has contributed to organizations such as Triplet Therapeutics, TRex Bio, Jnana Therapeutics, Arrakis Therapeutics, Palleon Pharmaceuticals, Nimbus Therapeutics, and Lodo Therapeutics Corporation from 2019 to 2021. Previously, Nikola held the role of Partner at Pfizer Ventures from September 2014 to December 2021, focusing on equity investments in early-stage biotech companies aimed at developing transformative therapeutics. Nikola earned a Ph.D. in Biophysics and Biochemistry from Columbia University between 2005 and 2009.